炎症性肠病医护工作者严重感染风险:GETAID病例对照研究
这项多中心病例对照研究纳入17个中心的482例炎症性肠病医护工作者,按性别、年龄、疾病亚型和诊断年份匹配482例非医护对照,随访至2016年6月,中位随访9.3年。医护工作者与非医护对照的严重感染总体发生率无差异,但医护工作者结核风险升高。全人群多变量分析显示严重感染与当前使用糖皮质激素、免疫抑制剂和抗TNF制剂相关。
要点
- 炎症性肠病医护工作者与非医护对照的严重感染总体发生率无差异。
- 医护工作者结核风险升高,使用抗TNF制剂时应评估结核暴露筛查。
- 当前使用糖皮质激素、免疫抑制剂和抗TNF制剂与严重感染风险升高相关。
核心结论
- 炎症性肠病医护工作者与其他炎症性肠病患者相比严重感染风险未升高,但结核除外。
- 作者建议在使用抗TNF制剂时对该高危人群评估结核暴露筛查。
研究设计与样本
- 大型多中心病例对照研究,纳入17个中心的482例炎症性肠病医护工作者,按性别、年龄、疾病亚型和诊断年份匹配482例非医护炎症性肠病对照。
- 研究期间为炎症性肠病诊断日期至2016年6月,中位随访9.3年。
- 严重感染定义为任何需住院的社区获得性感染。
主要发现
- 病例和对照共记录139例严重感染,包括30例艰难梭菌感染、33例严重病毒感染、9例结核感染、21例社区获得性肺炎和46例其他感染。
- 医护工作者与非医护对照的严重感染总体发生率无差异。
- 医护工作者中观察到结核风险升高。
- 全研究人群多变量分析中,严重感染与当前使用糖皮质激素相关(OR=3.05,95%CI [2.06-4.52],P<0.001)。
- 严重感染与当前使用免疫抑制剂相关(OR=1.98,95%CI [1.38-2.84],P<0.001),与当前使用抗TNF制剂相关(OR=2.93,95%CI [2.02-4.27],P<0.001),与克罗恩病呈负相关(OR=0.63,95%CI [0.43-0.91],P=0.01)。
临床怎么用
- 作者建议在使用抗TNF制剂时对炎症性肠病医护工作者评估结核暴露筛查。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Whether healthcare workers with inflammatory bowel disease (IBD) are at increased risk of severe infection due to daily pathogen exposure is controversial. AIM: To assess the risk of severe infection in healthcare workers with IBD in a large multicentre case-control study. METHODS: The study population comprised 482 healthcare workers with IBD from 17 centres who were matched for gender, age, disease subtype and year of diagnosis to 482 controls (non-healthcare workers with IBD). The study period was between the date of diagnosis of IBD and June 2016. Severe infection was defined as any community-acquired infection that required hospitalisation. RESULTS: With a median follow-up of 9.3 years, 139 severe infections were recorded among cases and controls, including 30 Clostridium difficile infections, 33 severe viral infections, nine tuberculosis infections, 21 community-acquired pneumonia and 46 others. No difference was observed between healthcare workers and controls regarding the overall incidence rates of severe infection. An increased risk of tuberculosis was noted in healthcare workers. In multivariate analysis in the entire study population, severe infection was associated with current exposure to corticosteroids (OR = 3.05, 95% CI [2.06-4.52], P < 0.001), immunosuppressants (OR = 1.98, 95% CI [1.38-2.84], P < 0.001) and anti-TNF agents (OR = 2.93, 95% CI [2.02-4.27], P < 0.001) and reduced with Crohn's disease (OR = 0.63, 95% CI [0.43-0.91], P = 0.01). CONCLUSIONS: Healthcare workers with IBD do not have an increased risk of severe infection compared with other patients with IBD, except for tuberculosis. Screening for tuberculosis exposure should be assessed in this high-risk population when treated with anti-TNF agents.
引用
- Gagnière C, Bourrier A, Seksik P, et al. Risk of serious infection in healthcare workers with inflammatory bowel disease: a case-control study of the Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID). Aliment Pharmacol Ther. 2018. PMID: 30069921. doi:10.1111/apt.14926
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。